← Back to Clinical Trials
Recruiting NCT01734122

NCT01734122 Stereotactic Radiosurgery for Essential Tremor and Parkinsonian Tremor

◆ AI Clinical Summary
Plain-language summary for patients
Clinical Trial Summary
NCT ID NCT01734122
Status Recruiting
Phase —
Sponsor Vanderbilt University Medical Center
Condition Tremor
Study Type OBSERVATIONAL
Enrollment 60 participants
Start Date 2013-02-21
Primary Completion 2028-09

Eligibility & Interventions

Sex All sexes
Min Age 18 Years
Max Age N/A
Study Type OBSERVATIONAL
Interventions
Questionnaires / Observational Assessments

Eligibility Fast-Check

Enter your details for a quick preliminary check. This does not replace medical advice.

What to Expect as a Participant

This is an observational study. You will not receive an experimental treatment; researchers will collect data based on your existing condition or standard treatment.

This trial targets 60 participants in total. It began in 2013-02-21 with a primary completion date of 2028-09.

⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.

Brief Summary

The purpose of this study is to determine the changes in quality of life and degree of tremor for patients with essential tremor or Parkinsonian tremor who are treated by stereotactic radiosurgery (SRS). This is a questionnaire-based study. Please see Detailed Description below for more information.

Eligibility Criteria

Inclusion Criteria: * Must be certified by a neurologist as having essential tremor or Parkinsonian tremor that is insufficiently controlled by medication alone. * Preference to receive radiation treatment for tremor treatment, rather than surgical DBS implantation or surgical thalamotomy * At least 18 years old Exclusion Criteria: * Contraindications to cranial radiation (such as prior radiation to the thalamus) * Inability to have a MRI of the brain * Prior surgical thalamotomy treatment (but contralateral deep brain stimulator \[DBS\] is permitted) * Estimated life expectancy less than 1 year

Frequently Asked Questions

Who can join the NCT01734122 clinical trial?

This trial is open to participants of all sexes, aged 18 Years or older, studying Tremor. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.

Is NCT01734122 currently recruiting?

Yes, NCT01734122 is actively recruiting participants. Visit ClinicalTrials.gov or contact Vanderbilt University Medical Center to inquire about joining.

Where is the NCT01734122 trial being conducted?

This trial is being conducted at Nashville, United States.

Who is sponsoring the NCT01734122 clinical trial?

NCT01734122 is sponsored by Vanderbilt University Medical Center. The trial plans to enroll 60 participants.

Related Trials

ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer  ·  Last Reviewed: November 2026  ·  Data Methodology